- Home
- DAR vs BMRN Comparison
DAR vs BMRN Comparison
Compare DAR & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAR | BMRN |
|---|---|---|
| Founded | 1882 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 10.4B |
| IPO Year | 2002 | 1999 |
Fundamental Metrics
Financial Performance| Metric | DAR | BMRN |
|---|---|---|
| Price | $59.45 | $56.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 18 |
| Target Price | $65.82 | ★ $88.22 |
| AVG Volume (30 Days) | 1.9M | ★ 2.2M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.83 | 0.54 |
| Revenue | ★ $6,135,877,000.00 | $1,313,646,000.00 |
| Revenue This Year | $7.78 | $15.02 |
| Revenue Next Year | $3.37 | $12.23 |
| P/E Ratio | ★ $73.21 | $104.61 |
| Revenue Growth | 7.36 | ★ 17.62 |
| 52 Week Low | $29.15 | $49.26 |
| 52 Week High | $66.02 | $66.28 |
Technical Indicators
Market Signals| Indicator | DAR | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 58.18 |
| Support Level | $58.42 | $51.74 |
| Resistance Level | $65.46 | $56.91 |
| Average True Range (ATR) | 1.67 | 1.89 |
| MACD | -0.04 | 0.53 |
| Stochastic Oscillator | 31.50 | 88.17 |
Price Performance
Historical ComparisonAbout DAR Darling Ingredients Inc.
Darling Ingredients Inc develops and produces sustainable natural ingredients from edible and inedible bio-nutrients for the pharmaceutical, food, pet food, animal feed, industrial, fuel, bioenergy, and fertilizer industries. The Company collects and processes animal by-products and recycled oils into ingredients. It operates through three reportable segments: Feed Ingredients, which generates maximum revenue and includes the collection and processing of animal by-products, used cooking oil, bakery residuals, pet food ingredients, hides, and fertilizers; Food Ingredients, which includes collagen, natural casings, and food-grade fats; and Fuel Ingredients, which includes renewable fuels, biogas, and energy products. The Company derives the majority of its revenue from North America.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.